Skip to content
Screener

Schering-Plough SGP Common Stock Par Value Per Share

Common Stock Par Value Per Share at other companies

HRO
HarrowHROW
$0.000.0%
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$0.000.0%
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
$0.000.0%

Other financials

Income statement

See full
Operating income-$15.4M-108%
Net income-$13.8M-56.6%
EPS (diluted)-$0.69+82.6%

Balance sheet

See full
Cash & equivalents$238.9M+312%
Total debt$1.6M
Total equity$250.1M+463%
Total assets$258.4M

Cash flow

See full
Operating cash flow-$13.5M-65.2%
CapEx$676.0K+312%
Free cash flow-$14.2M-70.0%

Valuation

See full
Market cap$827.48M-1.0%
Enterprise value$590.18M

Returns & leverage

See full
Return on equity-34.3%
Debt / equity
Current ratio38×

Where this comes from

Reported directly by Schering-Plough in its filing.

Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.

The source filing: Schering-Plough’s 10-K, filed March 26, 2026.

Filed
Mar 26, 2026, 5:23 PM EDT
Fiscal year
FY2025
Accession
0001778922-26-000020
(in thousands, except share and per share amounts)As of December 31, 2025As of December 31, 2024
Commitments and contingencies (Note 7)
Redeemable convertible preferred stock, $.00001 par value; 116,618,581 shares authorized, 20,341,968 and 9,608,914 shares issued and outstanding as of December 31, 2025 and 2024, respectively (aggregate liquidation preference of $200,878 and $73,542 as of December 31, 2025 and 2024, respectively)204,53772,546
Stockholders' deficit
Common stock, $.00001 par value; 154,383,336 shares authorized; 2,203,620 and 2,196,423 shares issued and outstanding as of December 31, 2025 and 2024, respectively
Common stock additional paid-in capital5,8934,387
Accumulated deficit(104,730)(64,861)
Total stockholders' deficit(98,837)(60,474)
Total liabilities, redeemable convertible preferred stock and stockholders' deficit$115,866$23,318

Item 8. [Financial Statements and Supplementary Data](#ifaf54775e85441fc836f60bc7c4f1464_4398046512509)

FAQ

What is Schering-Plough's common stock par value per share?
Schering-Plough (SGP) reported common stock par value per share of $0.00 in Q4 2025.
What does common stock par value per share mean?
The par value of common stock is the arbitrary legal value assigned to each share of common stock at the time of issuance. It is a legacy accounting requirement that has little impact on the actual market value or trading price of the shares.

Ask your AI about Schering-Plough's common stock par value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude